Islamabad:Muhammad Majid, born into a humble family in Fatomand in Gujranwala, found his life calling during his Ph.D journey at Tianjin University, China.
In a recent breakthrough, his review article titled “Aptamer-based electrochemical biosensors for breast cancer biomarkers: Developments, challenges, and future directions” was published in Analytical Chemistry, one of the world’s leading journals in the field.
“Saving a life does not begin in an operating room; it begins in a laboratory, with a sensor small enough to detect what the human eye cannot see,” he told China Economic Net in an interview.
“Field-effect transistor (FET)-based sensors aim at early cancer detection by identifying biomarkers at very early stages,” he told China Economic Net reporter in an interview.
In simple words, biomarkers are small biological signals the body releases when something is wrong. “If we can detect them early, we can detect cancer early. And early detection changes everything. When cancer is identified at an early stage, treatment success rates increase significantly. Patients can avoid much of the physical and emotional suffering that comes with late-stage therapies.
